Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation

Combined radiochemotherapy is the currently used therapy for locally advanced pancreatic ductal adenocarcinoma (PDAC), but normal tissue toxicity limits its application. Here we test the hypothesis that inhibition of ATR (ATM-Rad3-related) could increase the sensitivity of the cancer cells to radiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fokas, E, Prevo, R, Pollard, J R, Reaper, P M, Charlton, P A, Cornelissen, B, Vallis, K A, Hammond, E M, Olcina, M M, Gillies McKenna, W, Muschel, R J, Brunner, T B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542617/
https://www.ncbi.nlm.nih.gov/pubmed/23222511
http://dx.doi.org/10.1038/cddis.2012.181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542617/
https://www.ncbi.nlm.nih.gov/pubmed/23222511
http://dx.doi.org/10.1038/cddis.2012.181

Ejemplares similares